Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, May 14 2020

Full Issue

Gawande Plans To Step Down As Haven's CEO To Focus On Threats To Health From COVID-19

After two years in the role, Atal Gawande says his time is better spent now in an advisory position for the health care venture. He also just published an article in the New Yorker about how to safely reopen the country.

Stat: Gawande Says He's Leaving Haven CEO Job To Focus On Covid-19 

Atul Gawande on Wednesday confirmed that he will step down as chief executive of the health care company formed by Amazon, JPMorgan Chase & Co., and Berkshire Hathaway, saying it will allow him to devote more time to addressing the threats posed by Covid-19. Gawande said in a statement posted on Haven’s website that he will stay on as chairman of Haven’s board of directors and that a search has begun for a new chief executive officer. Mitch Betses, a longtime executive with CVS Health who became Haven’s chief operating officer in March, will oversee day-to-day operations. (Ross, 5/13)

The Wall Street Journal: Atul Gawande Steps Down As Haven’s CEO

Dr. Gawande, a prominent surgeon and professor at Harvard University, is taking on the less operational role of chairman, while Chief Operating Officer Mitch Betses will manage daily operations, Haven said Wednesday. The Wall Street Journal previously reported that Dr. Gawande was in talks to step down from his role. Dr. Gawande, who took the helm in July 2018, said the shift would enable him to focus on policy and advocacy work amid the Covid-19 pandemic. The venture said it is looking for a new CEO. (Sebastian, 5/13)

CNBC: How Haven Could Change Health Care Even Without Atul Gawande

Despite his departure, many health industry insiders agree that there’s still a path forward for Haven. The key will be for the executive teams to rally behind this person in a big way, and for this new recruit to bring benefits into lockstep with their plans. Get it right, and there’s still big upside. “Innovative employers, partnered with the best providers, are most empowered to fix United States health care,” said Jonathan Slotkin, chief medical officer of Contigo Health, an employer health-focused company that was formed inside Premier. “It really will take a partnership of the providers who deliver care and the employers who pay for that care,” he said. (Farr, 5/13)

Bloomberg: Berkshire-JPMorgan-Amazon Health Venture CEO Gawande Steps Down

Haven’s announcement sparked fears that the employer-led venture could compete with health insurers. But its first plans worked through existing insurance carriers. JPMorgan offered plans to about 30,000 workers in Ohio and Arizona, Bloomberg News reported in November. The Haven plans didn’t subject workers to deductibles and offered incentives for wellness activities to offset medical costs, similar to other corporate health initiatives.Haven kept its operations under wraps for months, with little public evidence of the ambitious ideas the initial rollout seemed to promise. (Armstrong and Tozzi, 5/13)

Modern Healthcare: Haven CEO Dr. Atul Gawande Leaves That Role, Named Chairman Of The Board

The leadership change fuels skepticism about what the ultimate impact will be of Haven, which its founders described as an independent company "free from profit-making incentives and constraints" with the aim of improving employee satisfaction and reducing healthcare costs for their U.S. employees. The companies have shared little detail about their efforts and strategy since the group was formed in early 2018. Gawande, who was announced as its CEO less than two years ago, said as he reflected on how he could best contribute to Haven, chairman of the board was an ideal role. Mitch Betses, chief operating officer, will manage day-to-day operations as Haven searches for a new CEO. (Kacik, 5/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF